BioHarvest Sciences Inc. reiterated its sales orders guidance for 2022. The company reiterated its 2022 sales orders guidance of USD 5 million - USD 7 million representing a 2.5 times - 3.5 times growth over 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.26 CAD | 0.00% | 0.00% | +20.93% |
1st Jan change | Capi. | |
---|---|---|
+20.93% | 105M | |
+5.54% | 7.44B | |
-2.62% | 7.21B | |
+0.22% | 5.8B | |
-8.57% | 3.65B | |
-14.55% | 3.29B | |
-15.31% | 1.16B | |
+12.72% | 940M | |
-39.38% | 907M | |
-16.51% | 851M |
- Stock Market
- Equities
- BHSC Stock
- News BioHarvest Sciences Inc.
- BioHarvest Sciences Inc. Reiterates Sales Orders Guidance for 2022